Influenza Clinical Trials: Active Studies by Market and Country

• 6markets with active trials
• 418active studies on Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs
• 30of our places with active trials

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

1. 1Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs418Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs: See them on ClinicalTrials.gov (opens in a new tab)
2. 2Influenza Antivirals251Influenza Antivirals: See them on ClinicalTrials.gov (opens in a new tab)
3. 3Influenza Vaccination72Influenza Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
4. 4Seasonal Influenza16Seasonal Influenza: See them on ClinicalTrials.gov (opens in a new tab)
5. 5Antipyretics OTC11Antipyretics OTC: See them on ClinicalTrials.gov (opens in a new tab)
6. 6Avian Influenza (H5N1)7Avian Influenza (H5N1): See them on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

• BPL-1357 Against H1N1 Influenza Virus Challenge

  NCT07215858Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs

• High-Dose Versus Standard-Dose Influenza Vaccine in Patients With Hematologic Malignancies Receiving B-Cell-Depleting Therapy

  NCT07926217Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs

• Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

  NCT01386424Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs

• Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

  NCT06863142Influenza Antivirals

• A Study to Evaluate the Safety of Subunit Influenza Vaccine in People Aged 6 Months and Older

  NCT07933458Influenza Vaccination

• Conversational AI for Adult Flu Vaccination Decisions

  NCT07896850Influenza Vaccination

• SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

  NCT05869968Influenza Vaccination

• A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children

  NCT07870330Seasonal Influenza

• A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age

  NCT07365826Seasonal Influenza

• Goflikicept for Resolution and Prevention of Attacks in Pediatric and Adolescent Patients With Colchicine-Resistant or Colchicine-Intolerant Familial Mediterranean Fever

  NCT07880886Antipyretics OTC

• Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)

  NCT06917001Antipyretics OTC

• Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults

  NCT06822907Antipyretics OTC

• Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)

  NCT07240558Avian Influenza (H5N1)

• A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

  NCT07128615Avian Influenza (H5N1)

• A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults

  NCT07496450Avian Influenza (H5N1)

Source: ClinicalTrials.gov, Study records, newest update first. Retrieved 12 Nov 2026.

• Flu and pneumonia death rate

• OTC medicines
• Respiratory
• Infectious diseases